Skip to content
  • Sunday, 26 July 2026
  • 4:32 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Atomic Roaming and the Hidden Drivers of Radiation Damage: A Breakthrough in Molecular Physics
Advanced Materials Science

Atomic Roaming and the Hidden Drivers of Radiation Damage: A Breakthrough in Molecular Physics

Nila Kartika Wati Apr 19, 2026 0

In a landmark study that bridges the gap between fundamental physics and biological preservation, an international team of researchers has…

Read More
Advanced Materials Science

Atomic Roaming Dynamics Reveal Hidden Mechanisms of Radiation Damage at the Molecular Level

Nila Kartika Wati Apr 12, 2026 0

In a landmark achievement for the field of molecular physics, an international team of researchers has successfully captured the real-time…

Read More
Advanced Materials Science

Atomic Roaming and the Dynamics of Radiation Damage: Scientists Map the Hidden Motion Preceding Molecular Decay

Nila Kartika Wati Apr 3, 2026 0

In a landmark achievement for the field of molecular physics, an international team of researchers has successfully captured the real-time…

Read More
Advanced Materials Science

Atomic Roaming and the Hidden Drivers of Radiation Damage: Scientists Capture Real-Time Motion Before Molecular Decay

Nila Kartika Wati Mar 25, 2026 0

The fundamental understanding of how high-energy radiation interacts with biological matter has taken a significant leap forward as an international…

Read More
Tirzepatide Shows Promising Adjunct Benefits in Type 1 Diabetes Management, Meta-Analysis Presented at European Congress on Obesity SuggestsSalk Institute Identifies Med14 Protein as Key Regulator for GLP-1 Agonists’ Long-Term Pancreatic Health BenefitsBMS claims pharma’s most powerful AI supercomputer. How it stacks up to Lilly’s and Roche’s.Sanofi’s Venglustat Receives Priority Review from US FDA for Type 3 Gaucher Disease
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ